TTK Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

1022.70 +117.75 ▲13.0%

24 March 2023, 04:01:00 PM
Volume: 265,085

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ttkhealthcare.com
Market Cap 1,445.11 Cr.
Enterprise Value(EV) 722.94 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.15 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 50.76 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 662.35 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.54 Calculated using Price: 1,022.70
Dividend Yield 0.98 Period Ending 2022-03
No. of Shares Subscribed 1.41 Cr. 14,130,333 Shares
FaceValue 10
Company Profile
T T K Healthcare Ltd was incorporated in 1958 and went public in the same year. The company's brand wagon consists of products that are sought after by a wide range of customers. The Woodward's Gripe Water brand is the market leader in the baby care category. The Eva range of personal care products (Talc, Deodorant, Skincare) bring together the gentle touch of nature, backed by TTK's extensive research.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+13.01%
1 Week
+18.92%
1 Month
+10.82%
3 Month
+7.97%
6 Month
+12.49%
1 Year
+23.45%
2 Year
+98.06%
5 Year
-3.50%
10 Year
+159.83%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 12.64 14.94 18.46 13.16 9.52 10.25 5.01 13.76 6.02
Return on Capital Employed (%) 18.12 20.71 23.85 18.63 15.42 15.46 8.28 8.38 8.59
Return on Assets (%) 5.51 6.27 7.85 6.38 5.28 5.99 2.94 8.04 3.56

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 107 118 136 157 233 251 249 295 330 928
Non Curr. Liab. 27 28 16 8 2 2 7 4 1 3
Curr. Liab. 106 129 150 120 168 157 172 189 221 300
Minority Int.
Equity & Liab. 240 275 303 285 403 411 427 488 551 1,231
Non Curr. Assets 77 109 119 118 147 139 129 113 102 97
Curr. Assets 163 166 184 167 256 272 298 375 449 1,133
Misc. Exp. not W/O
Total Assets 240 275 303 285 403 411 427 488 551 1,231

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 416 483 519 528 578 628 646 476 599 704
Other Income 6 7 6 6 8 8 9 10 16 38
Total Income 422 489 524 534 585 636 655 486 616 742
Total Expenditure -396 -453 -478 -489 -535 -578 -617 -457 -577 -683
PBIDT 26 36 46 44 50 57 37 29 38 59
Interest -3 -4 -3 -3 -5 -3 -3 -2 -3 -5
Depreciation -3 -6 -7 -12 -15 -15 -14 -13 -13 -13
Taxation -7 -10 -13 -10 -12 -15 -7 14 -6 -12
Exceptional Items 8 2
PAT 12 16 23 19 18 24 12 37 19 28
Adjusted EPS 16 21 29 24 13 17 9 26 13 20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 24 13 39 37 18 25 17 20 96 45
Cash Fr. Inv. -1 -15 -49 -27 5 -23 10 -13 -77 -31
Cash Fr. Finan. -2 2 3 -11 -23 -7 -31 -10 -17 -9
Net Change 22 0 -7 0 0 -4 -4 -4 2 5
Cash & Cash Eqvt 83 84 77 77 19 15 11 8 10 15

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56
Public 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44 25.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 09 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Loss / Misplacement of Share Certificates and Receipt of Application for issuance of Duplicate Share Certificates
Fri, 03 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Loss / Misplacement of Share Certificate and Receipt of Application for issuance of Duplicate Share Certificate
Fri, 17 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Loss / Misplacement of Share Certificate and Receipt of Application for issuance of Duplicate Share Certificate

Technical Scans View Details >>

Fri, 24 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On TTK Healthcare Ltd.

What is TTK Healthcare share price?
Can I buy TTK Healthcare shares now?
What is the Dividend Yield of TTK Healthcare?
What is the Market Cap of TTK Healthcare?
What are the key metrics to analyse TTK Healthcare?
What is the 52 Week High and Low of TTK Healthcare?
What is the trend of TTK Healthcare share price?